# Phase 3 anemia trials recruiting: 44 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 44 trials in phase 3 for anemia that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 anemia trials: 44 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/anemia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 44
- Recruiting or not yet: 44
- Read on: November 19, 2026

## Trials

The 25 newest of 44, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07940569 | Glutamine Early Start in Children With SCD Younger Than Five | Ain Shams University | Phase 3 | Not yet recruiting | Sickle Cell Disease (SCD) | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940569) |
| November 13, 2026 | NCT07935356 | A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia | Sponsor not shown (see the record) | Phase 3 | Recruiting | Thrombasthenia | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935356) |
| September 3, 2026 | NCT07801469 | Nutritional Optimization in Anemic Patients Scheduled for Elective Open-Heart Surgery | National Institute of Cardiovascular Diseases, Pakistan | Phase 3 | Not yet recruiting | Anemia, Iron Deficiency | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801469) |
| September 1, 2026 | NCT07798583 | OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and... | Indiana University | Phase 3 | Not yet recruiting | Malaria, Asymptomatic Malaria, Intermittent Preventive Treatment | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07798583) |
| July 30, 2026 | NCT07737262 | Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients | Peking University People's Hospital | Phase 3 | Not yet recruiting | Aplastic Anemia | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737262) |
| July 23, 2026 | NCT07722988 | A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes... | Kyntra Bio | Phase 3 | Not yet recruiting | Myelodysplastic Syndromes | 201 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07722988) |
| July 7, 2026 | NCT07687784 | A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia | AFT Pharmaceuticals, Ltd. | Phase 3 | Not yet recruiting | Iron Deficiency Anemia (IDA) | 1,366 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687784) |
| June 22, 2026 | NCT07661602 | How Precision Diets, Through Gut Bacteria, Affect Anemia in Nepalese Adolescent | Southern Medical University, China | Phase 3 | Not yet recruiting | Anemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661602) |
| June 18, 2026 | NCT07656415 | A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD) | Agios Pharmaceuticals, Inc. | Phase 3 | Recruiting | Sickle Cell Disease | 159 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07656415) |
| June 3, 2026 | NCT07623161 | A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib | Takeda | Phase 3 | Recruiting | Myelofibrosis, Anemia | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623161) |
| April 29, 2026 | NCT07556731 | Comparison of Ferrous Salt vs. Liposomal Iron in Adult Women With Iron-Deficiency Anemia | Hospital General de Mexico | Phase 3 | Not yet recruiting | Iron-deficiency Anemia (IDA), Hemoglobin, Iron Deficiencies, Adverse Effect | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07556731) |
| March 27, 2026 | NCT07498309 | Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease | University Hospital, Rouen | Phase 3 | Not yet recruiting | Vaso-Occlusive Crises, Sickle Cell Disease | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07498309) |
| March 23, 2026 | NCT07487727 | A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) | Kind Pharmaceuticals LLC | Phase 3 | Recruiting | Anemia Due to Chronic Kidney Disease | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07487727) |
| March 4, 2026 | NCT07450430 | Optimal Timing of Ketamine Initiation for SCD Pain | Boston Children's Hospital | Phase 3 | Not yet recruiting | Sickle Cell Disease, Sickle Cell Crisis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07450430) |
| February 20, 2026 | NCT07422480 | A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need... | Takeda | Phase 3 | Recruiting | Myelodysplastic Syndrome, Anemia | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422480) |
| February 2, 2026 | NCT07381426 | Ferric Citrate in Iron Deficiency Anemia During Pregnancy | Dhaka Medical College | Phase 3 | Recruiting | Anemia | 680 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07381426) |
| December 23, 2025 | NCT07300111 | A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With... | Qilu Pharmaceutical Co., Ltd. | Phase 3 | Not yet recruiting | Anaemia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07300111) |
| December 10, 2025 | NCT07274254 | Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease | Nantes University Hospital | Phase 3 | Recruiting | Vaso-Occlusive Pain Episode in Sickle Cell Disease | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07274254) |
| November 25, 2025 | NCT07247188 | Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease | Sanofi | Phase 3 | Recruiting | Sickle Cell Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247188) |
| July 25, 2025 | NCT07086976 | A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of... | Sanofi | Phase 3 | Recruiting | Autoimmune Haemolytic Anaemia | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07086976) |
| June 3, 2025 | NCT07001397 | Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag... | Peking Union Medical College Hospital | Phase 3 | Not yet recruiting | Aplastic Anemias | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07001397) |
| May 25, 2025 | NCT06989567 | A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute... | Asklepion Pharmaceuticals, LLC | Phase 3 | Not yet recruiting | Sickle Cell Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06989567) |
| May 16, 2025 | NCT06975865 | The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease | Sanofi | Phase 3 | Recruiting | Sickle Cell Disease | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06975865) |
| April 18, 2025 | NCT06934967 | Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients | Novartis Pharmaceuticals | Phase 3 | Recruiting | Paroxysmal Nocturnal Hemoglobinuria (PNH) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06934967) |
| March 19, 2025 | NCT06884280 | Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study | Hull University Teaching Hospitals NHS Trust | Phase 3 | Recruiting | Peritoneal Dialysis, Anaemia, Iron Deficiency, Anaemia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06884280) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 3 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 3 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| [AMAG Pharmaceuticals, Inc.](https://specstream.ai/data/clinical-trials/company/amag-pharmaceuticals-inc) | 2 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 2 |
| Assiut University | 1 |
| Hospital General de Mexico | 1 |
| Baylor College of Medicine | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| [Agios Pharmaceuticals, Inc.](https://specstream.ai/data/clinical-trials/company/agios-pharmaceuticals-inc) | 1 |
| Hull University Teaching Hospitals NHS Trust | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Nantes University Hospital | 1 |
| National Institute of Cardiovascular Diseases, Pakistan | 1 |
| Boston Children's Hospital | 1 |
| [Vertex Pharmaceuticals Incorporated](https://specstream.ai/data/clinical-trials/company/vertex-pharmaceuticals-incorporated) | 1 |
| Indiana University | 1 |
| London School of Hygiene and Tropical Medicine | 1 |
| George Washington University | 1 |
| [Kyntra Bio](https://specstream.ai/data/clinical-trials/company/kyntra-bio) | 1 |
| Kind Pharmaceuticals LLC | 1 |
| Ain Shams University | 1 |
| Dhaka Medical College | 1 |
| Saskatchewan Health Authority - Regina Area | 1 |
| Brown University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 21 |
| Italy | 9 |
| France | 9 |
| United Kingdom | 8 |
| Brazil | 8 |
| Germany | 8 |
| Poland | 7 |
| Spain | 7 |
| Canada | 6 |
| Turkey (Türkiye) | 6 |
| Saudi Arabia | 6 |
| Greece | 6 |
| Netherlands | 5 |
| Hungary | 5 |
| India | 5 |
| Mexico | 4 |
| Colombia | 4 |
| Australia | 4 |
| Bulgaria | 4 |
| Israel | 4 |
| Lithuania | 4 |
| Belgium | 4 |
| Czechia | 3 |
| Ireland | 3 |
| South Korea | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Patent law firms in the United States](https://specstream.ai/data/businesses/patent-law-firms/united-states)
- [Optometrists in the United States](https://specstream.ai/data/businesses/optometrists/united-states)
- [Naturopathic clinics in the United States](https://specstream.ai/data/businesses/naturopathic-clinics/united-states)
- [Metal fabricators in the United States](https://specstream.ai/data/businesses/metal-fabricators/united-states)
- [Maternity centers in the United States](https://specstream.ai/data/businesses/maternity-centers/united-states)
- [Lighting fixtures and equipment companies in the United States](https://specstream.ai/data/businesses/lighting-fixtures-and-equipment-companies/united-states)
